Prolonged Sevoflurane Inhalation Was Not Nephrotoxic in Two Patients with Refractory Status Asthmaticus

1996 ◽  
Vol 83 (1) ◽  
pp. 189-191 ◽  
Author(s):  
Naohisa Mori ◽  
Hirofumi Nagata ◽  
Sukejuro Ohta ◽  
Masahiro Suzuki
2021 ◽  
Vol 17 (1) ◽  
Author(s):  
Jan Benes ◽  
Roman Skulec ◽  
Dalibor Jilek ◽  
Ondrej Fibigr ◽  
Vladimir Cerny

AbstractRefractory status asthmaticus is the cause of rare cases of in-hospital death due to acute bronchial asthma. The most severe cases unresponsive to first, second and next line treatment may be fatal despite aggressive organ support with invasive ventilation and extracorporeal membrane oxygenation. Omalizumab, a humanized recombinant monoclonal anti-IgE antibody, is an approved add-on biological treatment for severe asthma. However, it is not indicated in an acute setting. Here, we report the case of a young patient with status asthmaticus fully dependent on extracorporeal membrane oxygenation refractory to any therapy for six days, who was successfully treated with omalizumab.


2010 ◽  
Vol 48 (1) ◽  
pp. 111-113 ◽  
Author(s):  
Christian Jung ◽  
Alexander Lauten ◽  
Ruediger Pfeifer ◽  
Philipp Bahrmann ◽  
Hans R Figulla ◽  
...  

2016 ◽  
Vol 73 (4) ◽  
Author(s):  
F. Guarracino ◽  
M. Stefani ◽  
P. Maremmani ◽  
M. Corini ◽  
S. Pini ◽  
...  

We describe a case of acute respiratory failure due to severe pneumonia triggered by the influenza A virus, rapidly evolving into a refractory status asthmaticus requiring emergent ECMO assistance, in order to facilitate the clinical management of patients suffering from this rare but life-threatening condition. This case report demonstrates that infection with influenza A virus can present with severe pneumonia and status asthmaticus refractory to medical and ventilatory treatment. When medical treatment and mechanical ventilation fail, extracorporeal membrane oxygenation therapy should not be delayed as it will avoid injury resulting from inadequate mechanical ventilation and lung hyperinflation.


1996 ◽  
Vol 83 (1) ◽  
pp. 189-191 ◽  
Author(s):  
Naohisa Mori ◽  
Hirofumi Nagata ◽  
Sukejuro Ohta ◽  
Masahiro Suzuki

Critical Care ◽  
2009 ◽  
Vol 13 (2) ◽  
pp. R29 ◽  
Author(s):  
Kiran B Hebbar ◽  
Toni Petrillo-Albarano ◽  
Wendy Coto-Puckett ◽  
Micheal Heard ◽  
Peter T Rycus ◽  
...  

2001 ◽  
Vol 14 (6) ◽  
pp. 455-460 ◽  
Author(s):  
Leopoldo R. Revich ◽  
Sebastián G. Grinspon ◽  
Carlos Paredes ◽  
Electra Moreno ◽  
Ricardo Gené ◽  
...  

2021 ◽  
Author(s):  
Jan Benes ◽  
Roman Skulec ◽  
Dalibor Jilek ◽  
Ondrej Fibigr ◽  
Vladimir Cerny

Abstract The presented case demonstrates the efficacy of omalizumab as a rescue therapy of refractory status asthmaticus associated with high IgE levels. Omalizumab should be considered in patients with status asthmaticus unresponsive to standard treatment.


Sign in / Sign up

Export Citation Format

Share Document